The Dangers of Xarelto and New Blood Thinners
Xarelto is part of the “new generation” of blood thinners intended to replace Coumadin (warfarin), a drug which has been available and effective to Americans coping with atrial fibrillation (AFIb) since the 1950s. While claimed to be easier to monitor, there is no reversal agent for Xarelto. Along with two other drugs in the same class known as Pradaxa and Eliquis, it is believed they are linked to more than 8,000 deaths since 2010 according to the Milwaukee Journal Sentinel/MedPage.
Current Investigations Into Xarelto
Update: Latest Developments In The Xarelto Case
Those numbers are shockingly high when compared to warfarin which was potentially attributed to 700 deaths during the same time period.
Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Germany-based, Bayer worked together to develop and market a drug that they saw a great financial opportunity in since millions of Americans use blood thinners each year. It is reported that together in 2015 Johnson & Johnson and Bayer sold about $2 billion worth of Xarelto, and in 2016 it earned more than $3.2 billion in sales.
Xarelto is expected to earn more than $6 billion in 2018 according to EvaluatePharma who conducted a study forecasting sales for the Top 10 pharmaceutical drugs in 2018.
On December 5th, 2017, a Philadelphia jury awarded a couple $27.8 million. The plaintiff, Lynn Hartman, said she took Xarelto, sold by J&J’s Janssen Pharmaceuticals unit, for more than a year before being hospitalized in 2014 with gastrointestinal bleeding she blamed on the drug.
As of January 2018, more than 21,000 lawsuits have been filed against the manufacturer.
If you or a loved one has suffered from uncontrollable bleeding resulting in hospitalization while taking Xarelto, you may contact us for a consultation which is free and has no obligation to file a lawsuit. Our attorneys can hear your case and the unique details and thereby provide you with reliable advice.
What Are Medical Professionals Saying?
According to the Knoxville News Sentinel, Rita Redberg, a cardiologist and editor of Journal of the American Medical Association, Internal Medicine said she has advised patients to wait a few years until the true risks and benefits of the new drugs are known.
“I don’t prescribe any of the newer oral anticoagulants,” said Redberg, a professor of medicine at the University of California, San Francisco. “My concern is that a lot of the people being put on the novel oral anticoagulants will have more harm than good.”
Injuries Related To Xarelto
While all drugs often carry side effects, the fact that this drug and others like it may cause irreversible harm, including death, has been the focal point for thousands who have been hospitalized, or have died, and their families have pursued justice on their behalf. Common blood thinners like Coumadin require monitoring to be sure that bleeding is not present and no harm comes to the individual. This is how Xarelto’s popularity grew, as it did not require the monitoring due to its “low therapeutic index.” The inherent problem lies within this low therapeutic index, which closes the window between safely taking a blood thinner and having the drug become deadly.
Injuries arising out of Xarelto use include:
- Bleeding gums
- Excessive bleeding after a surgery
- Gastrointestinal bleeding
- Rectal bleeding
- Cerebral hemorrhaging
While most doctors and dentists have been aware their patients have been using Xarelto and little harm has been done, for common falls and slight injuries, Xarelto has been linked to fatalities.
The FDA Rejects Xarelto’s Antidote
In August 2016 Portola Pharmaceuticals announced that the FDA did not approve the reversal antidote for Xarelto, leaving users of the drug in danger of uncontrollable bleeding. Pradaxa, a blood-thinning drug similar to Xarleto, had its antidote Praxbind approved in October 2015. Xarelto’s reversal agent is known as Andexxa, and remains pending approval as the FDA reviews Portola’s post-marketing commitments.
More Than 20,000 Lawsuits Filed
If you or someone you love has been injured or died from the use of Xarelto, you are not alone. Since 2015 our lawyers have filed Xarelto lawsuits on behalf of individuals throughout the United States.
As of January 2018, more than 21,400 lawsuits had been filed in a Multi-District Litigation, also known as an “MDL.” An MDL is created by the court to improve the efficiency of the legal process by consolidating all cases to one court and hopefully resolves these matters quickly on behalf of the claimants.
Multiple Partners at Searcy Denney are involved in the litigation, holding leadership roles and representing individuals and families just like yourself.
Contact Searcy Denney Today If Your Life Has Been Affected By Xarelto
While we can not turn back time or ease your loss, we do want to help. If you wish to hold the drug maker responsible, often a lawsuit is the only way to send the message to thousands of others. We can help make the process easy for you. You may contact our firm at any time by using our contact form, or by calling 800-388-3905.
If you or someone you love has been injured, please understand that time limits do apply! Please do not hesitate to contact us as we offer free consultations without obligation to hire our firm.